The Emergency Departments at St. Luke’s and Roosevelt Hospitals started transferring pediatric cases to The Mount Sinai Hospital on Tuesday, October 1, a day after the creation of the Mount Sinai Health System. These patient transfers are among the first systemwide synergies to be implemented throughout the seven campuses, and point to the fluidity of the Health System’s Inter-Hospital Transfer Center, which is open seven days a week, 24 hours a day.
It was standing room only at the campuses of Beth Israel Medical Center, St. Luke’s and Roosevelt Hospitals, and New York Eye and Ear Infirmary for a series of Town Hall meetings at which the leaders of the Mount Sinai Health System presented their vision for the future and how the new system will address today’s health care challenges.
The Boards of Trustees of The Mount Sinai Medical Center and Continuum Health Partners announced on Monday, September 30, the establishment of the Mount Sinai Health System. This new health system includes Icahn School of Medicine at Mount Sinai, seven major member hospital campuses in New York City, an extensive network of approximately 45 ambulatory care locations, 12 free-standing ambulatory surgery centers, and more than 40 clinical and academic relationships with local health care organizations—all throughout the greater metropolitan region.
The Mount Sinai Health System has launched a bold new era in community-based care that will provide world-class medical services to millions of people each year. Its vast geographic footprint includes seven member hospital campuses in Manhattan, from Chinatown to Chelsea, and midtown to Morningside Heights, as well as Queens and Brooklyn. It also extends into communities in each borough of New York City, Westchester, Long Island, and New Jersey.
The Icahn School of Medicine at Mount Sinai, one of the nation’s leading medical schools, along with its Graduate School of Biomedical Sciences, will serve to integrate all clinical and research missions for the seven member hospital campuses and vast network of ambulatory facilities in the new Mount Sinai Health System.
Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief at The Mount Sinai Medical Center, has been selected as the next Editor-in-Chief of the Journal of the American College of Cardiology (JACC), the world’s most widely read cardiovascular journal. His five-year term will begin in July 2014.
JACC is the flagship publication of the American College of Cardiology (ACC), a 43,000-member organization dedicated to improving cardiovascular care and heart health around the world through education, research, and advocacy.
A growing body of evidence suggests that the use of marijuana, or cannabis, can negatively impact the developing brains of approximately one in four adolescents, according to researchers at Icahn School of Medicine at Mount Sinai, and the University of Montreal.
The study, published in the August 16, 2013, issue of Neuropharmacology, highlights that the younger the user of cannabis, the more susceptible he or she is to delinquency, lower educational attainment, difficulty in conforming to an adult role, and mental health issues.
A new smartphone app that enables patients to provide immediate feedback on their experiences at the Derald H. Ruttenberg Treatment Center of The Tisch Cancer Institute is helping The Mount Sinai Hospital continue its efforts to provide exceptional care.
The app works this way: Upon arrival at the Ruttenberg Treatment Center, patients are asked to provide their cell phone numbers as they fill out their paperwork. Then the technology prompts them with a text message asking them to take a brief survey on their smartphones after they leave.
Every year, more than 1 million Americans develop liver damage caused by prescription and over-the-counter drugs, and dietary and herbal supplements. The condition, known as drug-induced liver injury (DILI), can result in severe liver disease that requires transplantation. There are no tests to predict who is at risk, or to help physicians make an early diagnosis, which would prevent progressive liver damage.
To address these challenges, and strengthen the capacity of health professionals and policymakers in Southeast Asia, Mount Sinai physicians under the leadership of Philip J. Landrigan, MD, MSc, the Ethel H. Wise Professor of Community Medicine and Dean for Global Health at The Mount Sinai Medical Center, have established a formal collaboration with the Chulabhorn Research Institute (CRI) in Bangkok, Thailand. Under the auspices of CRI and the World Health Organization (WHO), the physicians are sharing their knowledge and expertise with health care workers in Southeast Asia. Mount Sinai is world renowned for its work in environmental and occupational medicine.